Pro Dex Inc (PDEX) stock
PDEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 18/304% below fair value
$67.42−4.07 (-5.69%)
Close on Nov 12, 2026Market cap $215.74MP/E 18.6Yield –
Pro Dex ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Pro Dex's ebitda for the twelve months ending Sep 30, 2026 was $14.88M, up 23.7% year over year. For fiscal 2026 it was $14.39M, up 20.6% from the year before. Over ten years it grew 26.0% a year on average. The highest annual figure on record is $14.39M in fiscal 2026.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $14.39M | +20.6% |
| FY2025 | Jun 30, 2025 | $11.93M | +43.1% |
| FY2024 | Jun 30, 2024 | $8.33M | +25.9% |
| FY2023 | Jun 30, 2023 | $6.62M | +13.2% |
| FY2022 | Jun 30, 2022 | $5.85M | +12.2% |
| FY2021 | Jun 30, 2021 | $5.21M | -31.8% |
| FY2020 | Jun 30, 2020 | $7.64M | +40.5% |
| FY2019 | Jun 30, 2019 | $5.44M | +84.3% |
| FY2018 | Jun 30, 2018 | $2.95M | -10.4% |
| FY2017 | Jun 30, 2017 | $3.29M | +131.7% |
| FY2016 | Jun 30, 2016 | $1.42M | – |
| FY2015 | Jun 30, 2015 | -$324.00K | – |
| FY2014 | Jun 30, 2014 | -$287.00K | – |
| FY2013 | Jun 30, 2013 | -$1.31M | – |
| FY2012 | Jun 30, 2012 | -$718.00K | -117.2% |
| FY2011 | Jun 30, 2011 | $4.18M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $3.92M | +14.6% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $3.94M | +137.3% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $3.46M | -12.5% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $3.57M | +18.9% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $3.42M | +3.2% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $1.66M | -37.6% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $3.95M | +58.1% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $3.01M | +183.0% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $3.32M | +56.7% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $2.66M | +41.9% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $2.50M | +9.8% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $1.06M | -20.0% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $2.12M | +85.1% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $1.87M | +37.4% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $2.28M | +89.4% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $1.33M | -25.6% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $1.14M | -23.9% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $1.36M | +76.1% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $1.20M | -41.3% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $1.78M | +158.2% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $1.50M | -11.6% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $774.00K | -67.0% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $2.05M | +10.8% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $691.00K | -61.9% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $1.70M | +4.3% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $2.35M | +79.4% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $1.85M | +82.8% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $1.81M | +39.4% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $1.63M | -10.3% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $1.31M | +111.1% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $1.01M | +27.3% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $1.30M | +156.4% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $1.82M | +76.8% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $620.00K | -35.6% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $794.00K | -46.7% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $507.00K | +25.2% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $1.03M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $963.00K | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $1.49M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $405.00K | – |
See a number that looks wrong?